ArticleBMC cancer2013

Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models.

Oleksandr Ekshyyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.